Friess Associates LLC Chembio Diagnostics, Inc. Transaction History

Friess Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$2.88 - $5.64 $414,961 - $812,633	-144,084 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.4 - $7.97 $1.4 Million - $3.28 Million	-410,916 Reduced 74.04%	144,084 $506,000
Q4 2020 Feb 12, 2021	BUY	$4.11 - $7.51 $2.28 Million - $4.17 Million	555,000 New	555,000 $2.64 Million
Q2 2020 Aug 14, 2020	SELL	$3.18 - $15.54 $817,260 - $3.99 Million	-257,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.36 - $5.6 $606,520 - $1.44 Million	257,000 New	257,000 $1.32 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.